Synergistic effect of rapamycin and cyclosporine in prevention of acute kidney allograft rejection in the mouse

Microsurgery

Volumn 19, Issue 7, 1999, Pages 344-347

  Qi, Shijie ^a   Xu, Dasheng ^a   Peng, Junzheng ^a   Liu, Dingyi ^a   Chen, Huifang ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; DRUG EFFICACY; DRUG POTENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOMODULATION; KIDNEY ALLOGRAFT; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANIMALS; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SIROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033428489     PISSN: 07381085     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2752(1999)19:7<344::AID-MICR11>3.0.CO;2-S     Document Type: Conference Paper

References (28)

1. Vezina C, Kudeski A, Sehgal SN. Rapamycin (Ay-22,989), a new antifugal antibiotic. I. Taxonomy of the producing streptomycete and isolation of the active principle. J Antibiot 1975;28:721-726.
2. Sehgal SN, Baker H, Vezina C. Rapamycin (Ay-22,989). A new antifugal antibiotic. II. Fermentation, isolation and characterization. J Antibiot 1975;28:727-732.
3. Baker H, Sidorowicz A, Sehgal SN, Vezina C. Rapamycin (Ay-22,989), a new antifugal antibiotic. III. In vitro and in vivo evaluation. J Antibiot 1978;28:539-545.
4. Stepkowski SM, Kahan BD. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival. Transplant Proc 1991;23:3262-3264.
5. Collier DStJ, Calne R, Thiru S, et al. Rapamycin in experimental renal allografts in dogs and pigs. Transplant Proc 1990;22:1674-1675.
6. Collier DStJ, Calne RY, Pollard SG, et al. Rapamycin in experimental renal allografts in primates. Transplant Proc 1991;23:2246-2247.
7. Luo H, Duquid W, Chen H, Mohen M, Wu J. The effect of rapamycin on T cell development in mice. Eur J Immunol 1994;24:692-701.
8. Chen H, Luo H, Daloze P, et al. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in rats. Immunobiology 1993:188:303-315.
9. Kahan BD, Gibbons S, Tejpal N, Stepkowski SM, Chou TC. Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation 1991;51:232-239.
10. Tu Y, Stepkowski SM, Chou TC, Kahan BD. The synergistic effects of cyclosporine, sirolimus, and brequinar on heart allograft survival in mice. Transplantation 1995;59:177-183.
11. Kahan BD, Tejpal N, Gibbons-Stubbers S, et al. The synergistic interactions in vitro and in vivo of brequinar sodium with cyclosporine or rapamycin alone and in triple combination. Transplantation 1993; 55:894-900.
12. Chen H, Wu J, Xu D, et al. The effect of rapamycin on orthotopic small bowel transplantation in the rat. Transplant Proc 1992;24:1157-1158.
13. Chen H, Wu J, Luo H, Daloze P. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat. Transplant Proc 1992;24:892-893.
14. Thompson P, Xu D, Brunette I, Chen H. Combined effect of rapamycin and cyclosporine in prevention of rat corneal allograft rejection. Transplant Proc 1998;30:1033-1035.
15. Kerman RH, Kimball PM, Van Buren CT, Lewis RM, Kahan BD. Possible contribution of pretransplant immune responder status to renal allograft survival differences of black versus white recipients. Transplantation 1991;51:338-342.
16. Zhang Z, Schlachta C, Duff J, Stiller C, Grant D, Zhong R. Improved techniques for kidney transplantation in mice. Microsurgery 1995;16: 103-109.
17. Chou TC. The median-effect principle and combination index for quantitation of synergism and antagonism. In: Chou TC, Rideout D, editors. Synergism and antagonism in chemotherapy. San Diego: Academic; 1991. p 61.
18. Vu MD, Qi S, Xu D, et al. Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat. Transplantation 1997;64: 1853-1856.
19. Vu MD, Qi S, Xu D, et al. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat. Transplantation 1998;66:1575-1581.
20. Almond PS, Moss A, Nakhleh RE, et al. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in porcine renal allograft model. Transplantation 1993;56:275-281.
21. Ochiai T, Gunji Y, Nagata M, Akitoshi K, Asano T, Isono K. Effects of rapamycin in experimental organ allografting. Transplantation 1993;56:15-19.
22. Knight R, Ferraresso M, Serino F, Katz S, Lewis R, Kahan BD. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model. Transplantation 1993;55:947-949.
23. Hartner WC, Van der Werf WJ, Lodge JPA, et al. Effect of rapamycin on renal allograft survival in canine recipients treated with antilymphocyte serum, donor bone marrow, and cyclosporine. Transplantation 1995;60:1347-1374.
24. Kelly PA, Gruber SA, Behbod F, Kahan BD. Sirolimus, a new, potent immunosuppressive agent. Pharmacotherapy 1997;17:1148-1156.
25. Myers BD. Cyclosporine nephrotoxicity. Nephrol Forum 1986;30: 964-974.
26. Stepkowski SM, Chen H, Daloze P, Kahan BD. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat. Transplantation 1991;51:22-26.
27. Chen H, Wu J, Xu D, Luo H, Daloze P. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Transplantation 1993; 56:661-666.
28. Chen H, Qi S, Xu D, Wu J, Daloze P. The immunosuppressive effect of rapamycin on mouse small bowel transplantation. Transplantation 1996;61:523-526.